Endothelins in chronic liver disease

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 56, Issue 6, 1996, Pages 481-490

  Moller S ^a   Henriksen, J H ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

cirrhosis; endothelins; fluid retention; hyperdynamic circulation; neurohormonal dysregulation; portal hypertension

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN 3;

BLOOD VOLUME; CHRONIC LIVER DISEASE; DISEASE SEVERITY; FLUID TRANSPORT; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW;

EID: 0029848338     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365519609088803     Document Type: Review

References (19)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-155.
2. Masaki T, Yanagisawa M. Physiology and pharmacology of endothelins. Med Res Rev 1992; 12: 391-421.
3. Stephenson K, Gandhi CR, Olson MS. Biological actions of endothelin. Vitamins and Hormones Advances in Research and Applications 1994; 48: 157-98.
4. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989; 86: 2863-7.
5. Sakurai T, Goto K. Endothelins - Vascular actions and clinical implications. Drugs 1993; 46: 795-804.
6. Levin ER. Mechanisms of disease-Endothelins. N Engl J Med 1995; 333: 356-63.
7. Remuzzi G, Benigni A. Endothelins in the control of cardiovascular and renal function. Lancet 1993; 342: 589-93.
8. Nucci Gd, Thomas R, D'Orlean-Juste P, Antunes E, Walder C, Warner TD, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 9797-800.
9. Filep JG, Herman B, Battistini B, Chabrier PE, Braquet P, Sirois P. Antiaggregatory and hypotensive effects of endothelin-1 in beagle dogs: role for prostacyclin. J Cardiovasc Pharmacol 1991; 17(Suppl 7): S216-18.
10. Nord EP. Renal actions of endothelin. Kidney Int 1993; 44: 451-63.
11. Simonson MS. Endothelins: multifunctional renal peptides. Physiol Rev 1993; 73(2): 375-411.
12. Nakamoto H, Suzuki H, Murakami M, Kageyama Y, Naitoh M, Sakamaki Y, et al. Different effects of low and high doses of endothelin on haemodynamics and hormones in the normotensive conscious dog. J Hypertens 1991; 9: 337-44.
13. King AJ, Brenner BM. Renal and systemic hemodynamic actions of endothelin. In: Rubanyi GM, editor. Endothelin. New York: Oxford University Press, 1992: 158-78.
14. Miller WL, Redfield MM, Burnett JC Jr. Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 1989; 83: 317-20.
15. Pernow J, Hemsen A, Lundberg JM. Tissue specific distribution, clearance and vascular effects of endothelin in the pig. Biochem Biophys Res 1989; 161(2): 647-53.
16. Firth JD, Roberts FC, Raine EG Jr. Effect of endothelin on the function of the isolated perfused working rat heart. Clin Sci 1990; 7965: 221-6.
17. Goetz KL, Wang BC, Madwed JB, Zhu JL, Leadley RJ. Cardiovascular, renal, and endocrine responces to intravenous endothelin in conscious dogs. Am J Physiol 1993; 255: R1064-8.
18. Sorensen SS, Madsen JK, Pedersen EB. Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers. Am J Physiol 1994; 266: F411-F418.
19. Kurihari Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994; 368: 703-10.